5Agabiti-Rosei E, Muiesan ML. Left ventricular hypertrophy:How to influence an important risk factor in hypertension[J]. J Hypertens, 1998,16 (suppl) :S53-S58.
6Missault LH,DeBuyzere ML,Duprez DA,et al. Relationship between left ventricular mass and day or nighttime blood pressure in 649 patient with treated essential hypertension[J]. JACC,1999,33(2,Suppl A) :227A.
7Porush JG. Hypertension and chronic renal failure :the use of ACE inhibitors [J]. Am J Kidney Dis, 1998,31 : 177- 184.
8Goen G,Manni M,Giannoni MF,et al. Ischemic nephropathy in an elderly nephrologic and hypertensive population[J]. Am JNephrol,1998,18(3) :221-227.
9Hansson L, Zanchetti A, Carruthers G, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial.Lancet, 1998, 351:1755-1762.
10Hansson L, Zanchetti A, for the HOT Study Group. The Hypertension Optimal Treatment Study (the HOT Study).Blood Press, 1993,2:62-68.
1Meyers RS,Siu A. Pharmacotherapy review of chronic pediatric hy- pertension[J]. 2011,33 (10) : 1331-1356.
2Brown MJ,Mclnnes GT,Papst CC,et al. Aliskiren and the calcium channel blocker am lodipine as an initial treatment strategy for hy- pertension control (ACCELERATE) : A randomized, parallel-group tri- al[J]. Lancet, 2011,377 (9762) : 312-320.
